Results for tag: "Levomilnacipran"

Levomilnacipran is a medication used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. Levomilnacipran is available in both immediate-release and extended-release formulations. It is usually taken once or twice daily, with or without food. Common side effects include nausea, headache, insomnia, and dry mouth. The levomilnacipran market is a rapidly growing segment of the mental disorders drugs market. It is used to treat a wide range of mental health conditions, including depression, anxiety, and obsessive-compulsive disorder. Levomilnacipran is a relatively new medication, and its use is increasing as more people seek treatment for mental health issues. Some companies in the levomilnacipran market include Allergan, Pfizer, and Sun Pharmaceuticals. Allergan manufactures and markets the brand name Fetzima, while Pfizer manufactures and markets the brand name Fetzima XR. Sun Pharmaceuticals manufactures and markets the brand name Levomilnacipran ER. Show Less Read more